| 发明名称 | Random pentapolymer for treatment of autoimmune diseases | ||
| 摘要 | The present invention relates to a synthetic polypeptide which is a random linear pentapolymer comprising alanine, glutamic acid, lysine, tyrosine and phenylalanine and use thereof in treating autoimmune diseases, in particular multiple sclerosis. | ||
| 申请公布号 | US9200114(B2) | 申请公布日期 | 2015.12.01 |
| 申请号 | US201313764460 | 申请日期 | 2013.02.11 |
| 申请人 | MAPI PHARMA LTD. | 发明人 | Marom Ehud;Rubnov Shai |
| 分类号 | A61K38/02;A61K38/16;C08G69/10;C07K14/00;A61K31/785;A61K45/06;A61K38/00 | 主分类号 | A61K38/02 |
| 代理机构 | Rothwell, Figg, Ernst & Manbeck, P.C. | 代理人 | Rothwell, Figg, Ernst & Manbeck, P.C. |
| 主权项 | 1. A pentapolymer or a salt thereof, which is a linear random copolymer of alanine, glutamic acid, lysine, tyrosine and phenylalanine, wherein the molar ratio of alanine to glutamic acid to lysine to tyrosine to phenylalanine is about 2.5:1.9:4.5:1.0:0.9, respectively. | ||
| 地址 | Ness Ziona IL | ||